CrayoNano announces proposed appointments to Board of Directors and appointments to Senior Management

Current CEO Jo Uthus proposed as Chairman of the Board, succeeding Rune Rinnan who will step down from chairman position to vice chair of the board. UV-C LED industry veteran Dr. Ryan Chuo has taken the role of CTO to accelerate the UV-C LED technology development from CrayoNano's Taiwan office while Dr. Michael Peil continues in role as Senior Executive Vice President and Chief Revenue Officer and Chief Operating Officer Sveinung Ryen continues execution of the supply-chain and manufacturing. Jens Kielland will be acting CEO in this succession planning.

CrayoNano, the industry's only European fab-lite UV-C LED component supplier for disinfection and sterilization systems has experienced significant customer interest from hundreds of customers in the past 6 months and the market growth and demand for water, air and surface disinfection solutions utilizing highly efficient, highly robust UV-C LED components from CrayoNano has exceeded the company expectations.

Pending shareholder approval, Chairman Jo Uthus will oversee the strategy of the company, including equity financing as it enters a new phase of growth and expansion in the global market as the customer pipeline is fast-growing.

Jens Kielland will serve as CEO and has a decade long tenure in industrial companies Glamox and Elkem, in addition to SEB and has worked in the company since April 2022.

“With proposing Jo as Chairman and Jens as acting CEO, I can step down with full confidence in our succession plan and with the reassurance that the organization is in very capable hands. With the new phase of the company, we are moving to increase the semiconductor experience and network within the Board of Directors, which Jo will bring as the proposed chair of the company” states Rune Rinnan, Chairman of CrayoNano.

Changes to the Board of Directors is pending approval from the General Assembly, and the operational change is effective as of October 5, 2023.

Press contact:

Rune Rinnan
Chairman of the board
Email: rune.rinnan@ntechgroup.no
Phone: +47 900 56 028

Disclaimer:

This Presentation has been produced by CrayoNano AS (the “Company” or “CrayoNano”) as an update to its shareholders and may not be reproduced or redistributed, in whole or in part. To the best of the knowledge of the Company and its Board of Directors, the information contained in this Presentation is in all material respect in accordance with the facts as of the date hereof, and contains no material omissions likely to affect its import. However, no representation or warranty (express or implied) is made as to, and no reliance should be placed on, any information, including projections, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, arising directly or indirectly from the use of this Presentation. This Presentation contains information obtained from third parties. Such information has been accurately reproduced and no facts have been omitted that would render the reproduced information to be inaccurate or misleading, as far as the Company is aware and able to ascertain from the information published by these third parties.

“Forward looking statements”

An investment in the company involves risk, and several factors could cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements that may be expressed or implied by statements and information in this presentation. These factors include, e.g., risks or uncertainties associated with the company’s business, segments, development, growth management, financing, market acceptance and relations with customers, and, more generally, general economic and business conditions, changes in domestic and foreign laws and regulations, taxes, changes in competition and pricing environments, fluctuations in currency exchange rates and interest rates, and other factors. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this presentation.